AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3115449 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 31791380 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised behaviour change strategies delivered by neurophysiotherapists over a 12-month period.
Number of subjects: 0
Study 31791380 — intervention group
Group type: COMPARATOR
Intervention: Usual care during the 12-month study period.
Number of subjects: 0
Study 27787443 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab plus DHA (1,050 mg/day)
Number of subjects: 62
Study 27787443 — intervention group
Group type: COMPARATOR
Intervention: Intravitreal ranibizumab alone
Number of subjects: 62
Study 26457142 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive longitudinal online curriculum in bone health
Number of subjects: 50
Study 26457142 — intervention group
Group type: COMPARATOR
Intervention: Standard curriculum in bone health care alone
Number of subjects: 50
Study 24141644 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated multidisciplinary psycho‐oncological approach (IPA)
Number of subjects: 251
Study 24141644 — intervention group
Group type: COMPARATOR
Intervention: Structured anaesthesiology interview group (SAI)
Number of subjects: 251
Study 20674911 — intervention group
Group type: EXPERIMENTAL
Intervention: E(2) + P
Number of subjects: 288
Study 20674911 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG + P
Number of subjects: 288
Study 20674911 — intervention group
Group type: COMPARATOR
Intervention: P only
Number of subjects: 288
Study 19653341 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine (25 mg, allowed to double at week 2 if needed)
Number of subjects: 107
Study 19653341 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 17876402 — intervention group
Group type: EXPERIMENTAL
Intervention: aMCI
Number of subjects: 45
Study 17876402 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild AD
Number of subjects: 45
Study 17876402 — intervention group
Group type: COMPARATOR
Intervention: Normal Controls
Number of subjects: 45
Study 15113952 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly iron supplementation (120 mg iron as ferrous sulfate and 0.5 mg folic acid)
Number of subjects: 116
Study 15113952 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice weekly iron supplementation (60 mg iron and 0.25 mg folic acid)
Number of subjects: 116
Study 15113952 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice weekly iron supplementation
Number of subjects: 116
Study 15113952 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly iron supplementation
Number of subjects: 116
Study 11306774 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine (500 ml i.v. daily for 5 days)
Number of subjects: 40
Study 11306774 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 9522320 — intervention group
Group type: EXPERIMENTAL
Intervention: cyproterone acetate (5 mg p.o.)
Number of subjects: 30
Study 9522320 — intervention group
Group type: EXPERIMENTAL
Intervention: nomegestrol acetate (5 mg p.o.)
Number of subjects: 30
Study 9522320 — intervention group
Group type: EXPERIMENTAL
Intervention: progesterone (100 mg, vaginal cream)
Number of subjects: 30
Study 9522320 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy fertile women, n = 8)
Number of subjects: 30
Study 7699945 — intervention group
Group type: EXPERIMENTAL
Intervention: HLBI-VCAP combination therapy (Interferon-alpha + VCAP chemotherapy)
Number of subjects: 28
Study 7699945 — intervention group
Group type: COMPARATOR
Intervention: VCAP chemotherapy alone
Number of subjects: 28
Study 2892699 — intervention group
Group type: EXPERIMENTAL
Intervention: ferrous gluconate
Number of subjects: 14
Study 2892699 — intervention group
Group type: COMPARATOR
Intervention: placebo tablets
Number of subjects: 14
Study 30536293 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-suicidal self-injury (nssi)
Number of subjects: 1326
Study 30536293 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors for nssi
Number of subjects: 1326
Study 27806875 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose vitamin D3 supplementation
Number of subjects: 30
Study 27806875 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 24687891 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation
Number of subjects: 0
Study 24687891 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous device-aided drug delivery
Number of subjects: 0
Study 24687891 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-pharmacological approaches
Number of subjects: 0
Study 22013099 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g alcohol/d
Number of subjects: 51
Study 22013099 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g alcohol/d
Number of subjects: 51
Study 22013099 — intervention group
Group type: COMPARATOR
Intervention: Nonalcoholic placebo beverage
Number of subjects: 51
Study 20013463 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise on elbow flexors
Number of subjects: 12
Study 20013463 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise on knee flexors
Number of subjects: 12
Study 20013463 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise on both elbow and knee flexors
Number of subjects: 12
Study 17638583 — intervention group
Group type: EXPERIMENTAL
Intervention: GLOA (buprenorphine injection to the stellate ganglion)
Number of subjects: 0
Study 17638583 — intervention group
Group type: COMPARATOR
Intervention: SSB (saline injection to the stellate plus intramuscular buprenorphine)
Number of subjects: 0
Study 16036498 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 45
Study 16036498 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 45
Study 12435014 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass ionomer luting cement
Number of subjects: 20
Study 12435014 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc phosphate luting cement
Number of subjects: 20
Study 12435014 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc polycarboxylate luting cement
Number of subjects: 20
Study 10492735 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire measuring condom use in the last 10 coital acts
Number of subjects: 2266
Study 10492735 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrospective log of coital acts in the past two weeks
Number of subjects: 2266
Study 10492735 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaires based on the past month or six months
Number of subjects: 2266
Study 10492735 — intervention group
Group type: EXPERIMENTAL
Intervention: Use with partners who were not clients
Number of subjects: 2266
Study 8756806 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen monotherapy
Number of subjects: 12
Study 8756806 — intervention group
Group type: COMPARATOR
Intervention: NPPV
Number of subjects: 12
Study 8756806 — intervention group
Group type: COMPARATOR
Intervention: NPPV plus O2 therapy
Number of subjects: 12
Study 1348473 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation (20 mg daily)
Number of subjects: 222
Study 1348473 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222
Study 2865921 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose ketoconazole (800 mg/d)
Number of subjects: 134
Study 2865921 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose ketoconazole (400 mg/d)
Number of subjects: 134
Study 2865921 — intervention group
Group type: COMPARATOR
Intervention: Both low-dose and high-dose ketoconazole
Number of subjects: 134
Study 2865921 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole (both doses)
Number of subjects: 134
Study 31290983 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted insulin-adherence interventions
Number of subjects: 0
Study 31290983 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 29385640 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazoxide
Number of subjects: 30
Study 29385640 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 25262177 — intervention group
Group type: EXPERIMENTAL
Intervention: IV hydrocortisone (5 mg)
Number of subjects: 24
Study 25262177 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 22953792 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including interactive training and a software programme for dose adjustment
Number of subjects: 404
Study 22953792 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 404
Study 20701547 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumoperitoneum pressure of 8 mm Hg
Number of subjects: 100
Study 20701547 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumoperitoneum pressure of 10 mm Hg
Number of subjects: 100
Study 20701547 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumoperitoneum pressure of 12 mm Hg
Number of subjects: 100
Study 20701547 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumoperitoneum pressure of 14 mm Hg
Number of subjects: 100
Study 20701547 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of operation >45 minutes
Number of subjects: 100
Study 20701547 — intervention group
Group type: COMPARATOR
Intervention: Intraoperative analgesics
Number of subjects: 100
Study 20701547 — intervention group
Group type: COMPARATOR
Intervention: Use of drains
Number of subjects: 100
Study 18028738 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (150 mg/day for 5 days starting from day 3 of cycle)
Number of subjects: 68
Study 18028738 — intervention group
Group type: COMPARATOR
Intervention: Control group (normoovulatory obese women)
Number of subjects: 68
Study 15756629 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol-fluticasone combination (50 mcg salmeterol plus 500 mcg fluticasone, twice daily)
Number of subjects: 231
Study 15756629 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (inhaled steroid 1,000 mcg BDP equivalent plus LABA and/or theophylline and/or montelukast)
Number of subjects: 231
Study 11944382 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole, 20 mg twice daily (Group II)
Number of subjects: 130
Study 11944382 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic low-intensity laser irradiation (LILI) for 5 min, 6 to 8 procedures (Group III)
Number of subjects: 130
Study 11944382 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (Group I)
Number of subjects: 130
Study 11944382 — intervention group
Group type: COMPARATOR
Intervention: Control group (7 healthy subjects)
Number of subjects: 130
Study 7981575 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly diagnosed type 1 diabetes
Number of subjects: 88
Study 7981575 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-standing type 1 diabetes
Number of subjects: 88
Study 7981575 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 88
Study 7981575 — intervention group
Group type: COMPARATOR
Intervention: Prediabetic groups
Number of subjects: 88
Study 7981575 — intervention group
Group type: COMPARATOR
Intervention: Long-standing type 2 diabetes
Number of subjects: 88
Study 2661750 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone imaging
Number of subjects: 34
Study 2661750 — intervention group
Group type: COMPARATOR
Intervention: Supine imaging
Number of subjects: 34
Study 29603698 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser irradiation (λ = 2.94 μm, 60 mJ, 10 Hz)
Number of subjects: 32
Study 29603698 — intervention group
Group type: COMPARATOR
Intervention: Control (no laser irradiation)
Number of subjects: 32
Study 28880361 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-pool intravenous immunoglobulin (1 g/kg over 6 to 8 hours)
Number of subjects: 72
Study 28880361 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard intravenous immunoglobulin (approximately 1 g/kg as a single dose)
Number of subjects: 72
Study 28880361 — intervention group
Group type: COMPARATOR
Intervention: No platelet-enhancing therapy (Control Group C)
Number of subjects: 72
Study 26118558 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based limited channel portable monitoring followed by unattended autotitration with CPAP
Number of subjects: 373
Study 26118558 — intervention group
Group type: COMPARATOR
Intervention: Laboratory-based pathway with in-laboratory sleep study and CPAP titration
Number of subjects: 373
Study 26118558 — intervention group
Group type: COMPARATOR
Intervention: Laboratory arm
Number of subjects: 373
Study 26118558 — intervention group
Group type: EXPERIMENTAL
Intervention: Home arm
Number of subjects: 373
Study 22960240 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual mirror therapy
Number of subjects: 60
Study 22960240 — intervention group
Group type: EXPERIMENTAL
Intervention: Group mirror therapy
Number of subjects: 60
Study 22960240 — intervention group
Group type: COMPARATOR
Intervention: Control intervention with restricted view on the affected arm
Number of subjects: 60
Study 21518250 — intervention group
Group type: EXPERIMENTAL
Intervention: LNS-10gM
Number of subjects: 18
Study 21518250 — intervention group
Group type: EXPERIMENTAL
Intervention: LNS-20gM
Number of subjects: 18
Study 21518250 — intervention group
Group type: EXPERIMENTAL
Intervention: LNS-20gNoM
Number of subjects: 18
Study 21518250 — intervention group
Group type: COMPARATOR
Intervention: Nutributter
Number of subjects: 18
Study 19044299 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C (MMC) administered to 53 patients in the immediate postoperative period
Number of subjects: 105
Study 19044299 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-MMC group) with 52 patients
Number of subjects: 105
Study 16575109 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG in low dose (0.01 mg)
Number of subjects: 100000
Study 16575109 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG in high dose (1.0 mg)
Number of subjects: 100000
Study 16575109 — intervention group
Group type: EXPERIMENTAL
Intervention: Danish strain of BCG
Number of subjects: 100000
Study 16575109 — intervention group
Group type: EXPERIMENTAL
Intervention: French strain of BCG
Number of subjects: 100000
Study 16575109 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100000
Study 12944727 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymyxin B-immobilized fiber (PMX-F) hemoperfusion
Number of subjects: 46
Study 12944727 — intervention group
Group type: COMPARATOR
Intervention: Septic patients with encephalopathy
Number of subjects: 46
Study 10894974 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% colchicine gel
Number of subjects: 20
Study 10894974 — intervention group
Group type: COMPARATOR
Intervention: Hydrophilic gel (placebo)
Number of subjects: 20
Study 8846745 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral program
Number of subjects: 241
Study 8846745 — intervention group
Group type: COMPARATOR
Intervention: Individual education program
Number of subjects: 241
Study 8846745 — intervention group
Group type: COMPARATOR
Intervention: Group education program
Number of subjects: 241
Study 8846745 — intervention group
Group type: COMPARATOR
Intervention: Minimal instruction program
Number of subjects: 241
Study 8846745 — intervention group
Group type: COMPARATOR
Intervention: All programs
Number of subjects: 241
Study 8238148 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (60 mg) from 24 weeks' gestation until delivery
Number of subjects: 538
Study 8238148 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 538
Study 3807445 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentazocine (75 mg)
Number of subjects: 10
Study 3807445 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine (100 mg)
Number of subjects: 10
Study 3807445 — intervention group
Group type: COMPARATOR
Intervention: Diazepam (0.25 mg/kg)
Number of subjects: 10
Study 3807445 — intervention group
Group type: COMPARATOR
Intervention: Pentazocine + Diazepam
Number of subjects: 10
Study 3807445 — intervention group
Group type: COMPARATOR
Intervention: Codeine + Diazepam
Number of subjects: 10
Study 3807445 — intervention group
Group type: COMPARATOR
Intervention: Opiates + Diazepam
Number of subjects: 10
Study 31894843 — intervention group
Group type: EXPERIMENTAL
Intervention: Wuling capsule
Number of subjects: 66
Study 31894843 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 29971999 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal needling combined with tuina
Number of subjects: 90
Study 29971999 — intervention group
Group type: COMPARATOR
Intervention: Conventional tuina
Number of subjects: 90
Study 27470569 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin (80mg) plus Benazepril (10mg)
Number of subjects: 92
Study 27470569 — intervention group
Group type: COMPARATOR
Intervention: Fluvastatin (80mg)
Number of subjects: 92
Study 24447629 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 40 mg
Number of subjects: 112
Study 24447629 — intervention group
Group type: COMPARATOR
Intervention: Ezetimibe/Simvastatin 10/40 mg
Number of subjects: 112
Study 23662659 — intervention group
Group type: EXPERIMENTAL
Intervention: Static progressive stretch orthosis with physical therapy
Number of subjects: 60
Study 23662659 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy alone
Number of subjects: 60
Study 20128949 — intervention group
Group type: EXPERIMENTAL
Intervention: Life-review course 'Looking for Meaning'
Number of subjects: 171
Study 20128949 — intervention group
Group type: COMPARATOR
Intervention: Movie (comparison group)
Number of subjects: 171
Study 18559037 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral t-tube insertion in one ear
Number of subjects: 7
Study 18559037 — intervention group
Group type: COMPARATOR
Intervention: No treatment in the other ear (control)
Number of subjects: 7
Study 15568188 — intervention group
Group type: EXPERIMENTAL
Intervention: New formula for sample size calculations for comparative clinical trials with Poisson or over-dispersed Poisson process data
Number of subjects: 0
Study 15568188 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of the formula to a trial for chronic granulomatous disease
Number of subjects: 0
Study 11809161 — intervention group
Group type: EXPERIMENTAL
Intervention: Age transformation of hippocampus-amygdala formation (HAF) volume
Number of subjects: 55
Study 11809161 — intervention group
Group type: EXPERIMENTAL
Intervention: Age transformation of HAF volume
Number of subjects: 55
Study 11809161 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects (no intervention)
Number of subjects: 55
Study 10522247 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (7.3 mg sublingual tablets)
Number of subjects: 20
Study 10522247 — intervention group
Group type: COMPARATOR
Intervention: Methadone (63 mg oral)
Number of subjects: 20
Study 10522247 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Buprenorphine and Methadone
Number of subjects: 20
Study 10522247 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 20
Study 8927531 — intervention group
Group type: EXPERIMENTAL
Intervention: Push handle height at 86.5% of shoulder height (1.191 +/- 0.034 m)
Number of subjects: 8
Study 8927531 — intervention group
Group type: EXPERIMENTAL
Intervention: Push handle heights of 61%, 69.5%, 78%, 86.5%, and 95% of shoulder height
Number of subjects: 8
Study 8927531 — intervention group
Group type: COMPARATOR
Intervention: Low pushing handles
Number of subjects: 8
Study 1836754 — intervention group
Group type: EXPERIMENTAL
Intervention: DMPA
Number of subjects: 20
Study 1836754 — intervention group
Group type: EXPERIMENTAL
Intervention: NET-EN
Number of subjects: 20
Study 7000029 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine sulfate
Number of subjects: 59
Study 7000029 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenfluramine hydrochloride
Number of subjects: 59
Study 7000029 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 30866980 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on health belief model (HBM) delivered in four training sessions about physical activity and nutrition.
Number of subjects: 0
Study 30866980 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 0
Study 27688313 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological pain treatments
Number of subjects: 125
Study 27688313 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpharmacological pain treatments
Number of subjects: 125
Study 27688313 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher ability to communicate
Number of subjects: 125
Study 27688313 — intervention group
Group type: EXPERIMENTAL
Intervention: Fewer pain locations
Number of subjects: 125
Study 27688313 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer duration in nursing home
Number of subjects: 125
Study 27688313 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dependency
Number of subjects: 125
Study 26101174 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifampridine phosphate salt (20 mg base equivalents per dose) under fed conditions
Number of subjects: 47
Study 26101174 — intervention group
Group type: COMPARATOR
Intervention: Amifampridine phosphate salt (20 mg base equivalents per dose) under fasted conditions
Number of subjects: 47
Study 26101174 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifampridine phosphate salt (20 mg base equivalents per dose)
Number of subjects: 47
Study 25627992 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch 130/0.4 (n=86)
Number of subjects: 111
Study 25627992 — intervention group
Group type: COMPARATOR
Intervention: Ringer's lactate (n=25)
Number of subjects: 111
Study 25627992 — intervention group
Group type: EXPERIMENTAL
Intervention: Ringer's lactate (500 ml preload)
Number of subjects: 111
Study 25627992 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional fluid boluses
Number of subjects: 111
Study 25627992 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid volume optimization
Number of subjects: 111
Study 25627992 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood volume expansion
Number of subjects: 111
Study 20678132 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediately placed implants in sockets without periapical pathology (test group)
Number of subjects: 29